Marina Moran Moset

Title: Marina Moran Moset: Innovator in Chemical Compounds

Introduction

Marina Moran Moset is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of chemical compounds, particularly in the development of inhibitors for serine/threonine and tyrosine kinase activity. With a total of 5 patents to her name, her work has implications for treating various diseases, including cancer.

Latest Patents

One of her latest patents involves 2-pyrazolin-5-ones, which are chemical compounds that serve as inhibitors of serine/threonine and tyrosine kinase activity. These compounds are particularly noteworthy as they can ameliorate disease states where angiogenesis or endothelial cell hyperproliferation is a factor. This makes them valuable in the treatment of cancer and hyperproliferative disorders. Another significant patent she holds is for bis-naphthalimides, which are also aimed at cancer treatment. These compounds and their pharmaceutical compositions are designed to provide therapeutic benefits in oncology.

Career Highlights

Throughout her career, Marina has worked with notable companies such as BASF Aktiengesellschaft and Knoll Aktiengesellschaft. Her experience in these organizations has allowed her to refine her expertise in chemical innovation and patent development.

Collaborations

Marina has collaborated with several professionals in her field, including Gerhard Keilhauer and Cynthia A Romerdahl. These collaborations have contributed to her success and the advancement of her research.

Conclusion

Marina Moran Moset is a distinguished inventor whose work in chemical compounds has the potential to impact the treatment of serious health conditions. Her innovative patents and collaborations highlight her significant role in the field of chemical research.